Karyopharm to participate at 11th annual svb leerink global healthcare conference

Newton, mass., feb. 11, 2022 /prnewswire/ -- karyopharm therapeutics inc. (nasdaq: kpti), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that richard paulson, president and chief executive officer of karyopharm, will participate in a fireside chat at the 11th annual svb leerink global healthcare conference.
KPTI Ratings Summary
KPTI Quant Ranking